DxDiscovery

About:

DxDiscovery is a biotechnology research and development firm.

Website: http://www.dxdiscovery.com/

Top Investors: U.S. Department of Health & Human Services

Description:

DxDiscovery is a research and development company for biotechnology. The creation of moderate, microbial monoclonal antibody antibodies is the corporate objective. These antibodies may be created as preventatives or treatments for infectious diseases, or they may be used in quick POC diagnostics. Products in their diagnostics portfolio will help in circumstances when the existing treatment protocol is time-consuming or very likely to yield erroneous results.

Total Funding Amount:

$600000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Reno, Nevada, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)dxdiscovery.com

Founders:

David AuCoin, Thomas Kozel

Number of Employees:

11-50

Last Funding Date:

2013-08-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai